52768 Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Notices 

2FDA has verified the Web site address, but FDA 

is not responsible for any subsequent changes to the 

Web site after this document publishes in the 

Federal Register. 

Drug Administration, 5600 Fishers 

Lane, rm. 6–30, Rockville, MD 20857. 

VII. References 

1. ‘‘Useful Written Consumer 

Medication Information (CMI)’’ 

published in July 2006, available on the 

Internet at http://www.fda.gov/ 

downloads/Drugs/GuidanceCompliance

RegulatoryInformation/Guidances/ 

ucm080602.pdf. 

2. Kimberlin CL, Winterstein AG. 

‘‘Expert and Consumer Evaluation of 

Consumer Medication Information— 

2008.’’ Final Report to FDA. November 

2008 available on the Internet at http:// 

www.fda.gov/downloads/AboutFDA/ 

CentersOffices/CDER/ReportsBudgets/ 

UCM163783.pdf. 

3. FDA’s Risk Communication 

Advisory Committee meeting, held on 

February 26 and 27, 2009 (73 FR 74505, 

December 8, 2008), available on the 

Internet at http://www.fda.gov/ 

downloads/AdvisoryCommittees/ 

CommitteesMeetingMaterials/ 

RiskCommunication

AdvisoryCommittee/UCM152593.pdf. 

4. ‘‘Providing Effective Information to 

Consumers about Prescription Drug 

Risks and Benefits—The Issues Paper’’ 

from the 2009 public workshop 

available on the Internet at http:// 

www.fda.gov/downloads/Drugs/ 

NewsEvents/UCM182799.pdf. 

5. ‘‘Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Experimental Study 

of Patient Information Prototypes,’’ 

available on the Internet at2 http:// 

edocket.access.gpo.gov/2010/pdf/2010- 

10359.pdf 

Dated: August 23, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–21326 Filed 8–26–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0002] 

Withdrawal of Approval of New Animal 

Drug Applications; Dichlorophene and 

Toluene Capsules 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is withdrawing 

approval of two new animal drug 

applications (NADAs) for use of 

dichlorophene and toluene deworming 

capsules for cats and dogs. In a final 

rule published elsewhere in this issue of 

the Federal Register, FDA is amending 

the regulations to remove portions 

reflecting approval of these NADAs. 

DATES: Withdrawal of approval is 

effective September 7, 2010. 

FOR FURTHER INFORMATION CONTACT: John 

Bartkowiak, Center for Veterinary 

Medicine (HFV–212), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9079; 

email: john.bartkowiak@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Pegasus 

Laboratories, Inc., 8809 Ely Rd., 

Pensacola, FL 32514 has requested that 

FDA withdraw approval of NADA 101– 

497 for TINY TIGER (dichlorophene/ 

toluene) Worming Capsules, NADA 

101–498 for LK (dichlorophene/toluene) 

Worming Capsules because they are no 

longer manufactured or marketed. 

Therefore, under authority delegated 

to the Commissioner of Food and Drugs 

and redelegated to the Center for 

Veterinary Medicine, and in accordance 

with § 514.116 Notice of withdrawal of 

approval of application (21 CFR 

514.116), notice is given that approval 

of NADAs 101–497 and 101–498, and 

all supplements and amendments 

thereto, is hereby withdrawn, effective 

September 7, 2010. 

In a final rule published elsewhere in 

this issue of the Federal Register, FDA 

is amending the animal drug regulations 

to reflect the withdrawal of approval of 

these NADAs. 

Dated: August 23, 2010. 

Bernadette Dunham, 

Director, Center for Veterinary Medicine. 

[FR Doc. 2010–21295 Filed 8–26–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2010–0071] 

National Protection and Programs 

Directorate; Agency Information 

Collection Activities: Office of 

Infrastructure Protection; Chemical 

Security Awareness Training Program 

AGENCY: National Protection and 

Programs Directorate, DHS. 

ACTION: 60-Day notice and request for 

comments. 

Extension of a Currently Approved 

Information Collection: 1670–0009. 

SUMMARY: The Department of Homeland 

Security, National Protection and 

Programs Directorate, Office of 

Infrastructure Protection, SectorSpecific Agency Executive Management 

Office (NPPD/SSA EMO), submits the 

following Information Collection 

Request (ICR) to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995 (Pub. L. 104–13, 44 U.S.C. Chapter 

35). 

DATES: Comments are encouraged and 

will be accepted until October 26, 2010. 

This process is conducted in accordance 

with 5 CFR 1320.1. 

ADDRESSES: Written comments and 

questions about this Information 

Collection Request should be forwarded 

to the Department of Homeland 

Security, NPPD/SSA EMO, Chemical 

Sector-Specific Agency, 245 Murray 

Lane, SW., Mail Stop 0608, Washington, 

DC 20528–0608. E-mailed requests 

should go to Amy Graydon at 

chemicalsector@dhs.gov. Written 

comments should reach the contact 

person listed no later than October 26, 

2010. Comments must be identified by 

DHS–2010–0071 and may be submitted 

by one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. 

• E-mail: chemicalsector@dhs.gov. 

Include the docket number in the 

subject line of the message. 

Instructions: All submissions received 

must include the words ‘‘Department of 

Homeland Security’’ and the docket 

number for this action. Comments 

received will be posted without 

alteration at http://www.regulations.gov, 

including any personal information 

provided. 

SUPPLEMENTARY INFORMATION: The 

Chemical Sector-Specific Agency, 

within the DHS NPPD/SSA EMO, 

provides an on-line voluntary training 

program to improve security in the 

chemical industry sector. Information is 

automatically collected in a computer 

database as a result of individuals 

engaging in the training. Explicit 

reporting or recordkeeping is not 

required. The training is designed for 

the general chemical facility employee. 

U.S. chemical industry direct 

employment is about 850,000 (2009 per 

the American Chemistry Council); 

approximately 400,000 employees are 

estimated as potential participants. 

Estimated duration in the first year to 

complete the registration, training, and 

survey is 60 minutes, and less if 

individuals take refresher training in 

succeeding years. Minimal participation 

data is collected as trainees complete 

the online exercises. Upon completion, 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Notices 52769 

a Certificate of Completion is generated 

at the trainee’s computer work station, 

printed, and optionally e-mailed to a 

facility supervisor. DHS will monitor 

program participation, success in 

training, and basic distribution variables 

submitted upon registration. Training 

information and survey responses 

gathered will be used for program 

review purposes only. Personally 

identifiable information, such as the 

trainee’s name when optionally entered 

on the printable certificate, will not be 

stored in the system. In addition, e-mail 

addresses and other contact information 

are not requested to complete the 

training. To protect privacy, users will 

be asked to create a generic user ID, 

password, and password retrieval 

question and answer. 

The Office of Management and Budget 

is particularly interested in comments 

which: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

Analysis 

Agency: Department of Homeland 

Security, National Protection and 

Programs Directorate. 

Title: Chemical Security Awareness 

Training Program (CSATP). 

OMB Number: 1670–0009. 

CSATP Registration 

Frequency: Annually. 

Affected Public: Private Sector. 

Number of Respondents: 400,000. 

Estimated Time Per Respondent: .17 

hours. 

Total Burden Hours: 68,000 annual 

burden hours. 

Total Burden Cost (capital/startup): 

$0. 

Total Burden Cost (operating/ 

maintaining): $2,720,000. 

CSATP Module 

Frequency: Annually. 

Affected Public: Private Sector. 

Number of Respondents: 400,000. 

Estimated Time Per Respondent: .66 

hours. 

Total Burden Hours: 264,000. 

Total Burden Cost (capital/startup): 

$0. 

Total Burden Cost (operating/ 

maintaining): $10,560,000. 

CSATP Survey 

Frequency: Annually. 

Affected Public: Private Sector. 

Number of Respondents: 400,000. 

Estimated Time Per Respondent: .17 

hours. 

Total Burden Hours: 68,000. 

Total Burden Cost (capital/startup): 

$0. 

Total Burden Cost (operating/ 

maintaining): $2,720,000. 

Signed: August 18, 2010. 

David Epperson, 

Acting Chief Information Officer, National 

Protection and Programs Directorate, 

Department of Homeland Security. 

[FR Doc. 2010–21373 Filed 8–26–10; 8:45 am] 

BILLING CODE 9110–9P–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Office of the Secretary 

[Docket No. DHS–2010–0060] 

DHS Data Privacy and Integrity 

Advisory Committee 

AGENCY: Privacy Office, DHS. 

ACTION: Notice of Federal Advisory 

Committee meeting. 

SUMMARY: The DHS Data Privacy and 

Integrity Advisory Committee will meet 

on September 28, 2010, in Washington, 

DC. The meeting will be open to the 

public. 

DATES: The DHS Data Privacy and 

Integrity Advisory Committee will meet 

on Tuesday, September 28, 2010, from 

8:30 a.m. to 1 p.m. Please note that the 

meeting may end early if the Committee 

has completed its business. 

ADDRESSES: The meeting will be held in 

the Carl Hayden Room, U.S. 

Government Printing Office, 732 North 

Capitol Street, NW., 8th floor, 

Washington, DC 20401. Written 

materials, requests to make oral 

presentations, and requests to have a 

copy of your materials distributed to 

each member of the Committee prior to 

the meeting should be sent to Martha K. 

Landesberg, Executive Director, DHS 

Data Privacy and Integrity Advisory 

Committee, by September 21, 2010. 

Persons who wish to submit comments 

and who are not able to attend or speak 

at the meeting may submit comments at 

any time. All submissions must include 

the Docket Number (DHS–2010–0060) 

and may be submitted by any one of the 

following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• E-mail: PrivacyCommittee@dhs.gov. 

Include the Docket Number (DHS– 

2010–0060) in the subject line of the 

message. 

• Fax: (703) 483–2999. 

• Mail: Martha K. Landesberg, 

Executive Director, Data Privacy and 

Integrity Advisory Committee, 

Department of Homeland Security, 

Washington, DC 20528. 

Instructions: All submissions must 

include the words ‘‘Department of 

Homeland Security Data Privacy and 

Integrity Advisory Committee’’ and the 

Docket Number (DHS–2010–0060). 

Comments will be posted without 

alteration at http://www.regulations.gov, 

including any personal information 

provided. 

Docket: For access to the docket to 

read background documents or 

comments received by the DHS Data 

Privacy and Integrity Advisory 

Committee, go to http:// 

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Martha K. Landesberg, Executive 

Director, DHS Data Privacy and Integrity 

Advisory Committee, Department of 

Homeland Security, Washington, DC 

20528, by telephone (703) 235–0780, by 

fax (703) 235–0442, or by e-mail to 

PrivacyCommittee@dhs.gov. 

SUPPLEMENTARY INFORMATION: Notice of 

this meeting is given under the Federal 

Advisory Committee Act (FACA), 5 

U.S.C. App. 2. During the meeting, the 

Chief Privacy Officer will provide the 

DHS Data Privacy and Integrity 

Advisory Committee an update on the 

activities of the DHS Privacy Office. In 

support of the Committee’s ongoing 

advice to the Department on 

implementing privacy protections in 

DHS operations, the Committee will 

also hear and discuss presentations on 

building accountability in the DHS 

privacy compliance assessment process, 

on privacy training in DHS, and on DHS 

Customs and Border Protection (CBP) 

implementation of DHS privacy policy. 

The agenda will be posted in advance of 

the meeting on the Committee’s Web 

site at http://www.dhs.gov/privacy. 

Please note that the meeting may end 

early if all business is completed. 

If you wish to attend the meeting, 

please plan to arrive by 8:15 a.m. to 

allow extra time to be processed through 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES